Earnings History Data for Gilead Sciences, Inc. (GILD) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Gilead Sciences, Inc.

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The Company strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions. Their portfolio of marketed products includes a number of category firsts, including complete treatment regimens for HIV infection available in a once-daily single pill and the first oral antiretroviral pill available to reduce the risk of acquiring HIV infection in certain high-risk adults.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
25-04-2024 AH GILD Gilead Sciences, Inc. 83,500 -1.32 -0.23 1.37 Gilead Sciences Non-GAAP EPS of -$1.32 beats by $0.20, revenue of $6.69B beats by $350M
[4/25/2024 4:04 PM]
65.42 0.15 
(0.23%)
65.93 0.66 
(1.01%)
64.63 - 87.86 10,384,131 7,530,000 29,676
06-02-2024 AH GILD Gilead Sciences, Inc. 95,900 1.72 1.76 1.67 Gilead Sciences Non-GAAP EPS of $1.72 misses by $0.04, revenue of $7.12B beats by $20M
[2/6/2024 4:03 PM]
74.48 -3.24 
(-4.17%)
76.26 -1.46 
(-1.88%)
72.87 - 87.86 9,748,475 7,380,000 17,994
07-11-2023 AH GILD Gilead Sciences, Inc. 101,660 2.29 1.91 1.90 Gilead Sciences Non-GAAP EPS of $2.29 beats by $0.38, revenue of $7.05B beats by $260M
[11/7/2023 4:05 PM]
77.90 -2.71 
(-3.36%)
77.47 -3.14 
(-3.89%)
72.87 - 89.74 10,765,728 5,820,000 67,821
03-08-2023 AH GILD Gilead Sciences, Inc. 94,400 1.34 1.60 1.58 Gilead Sciences Non-GAAP EPS of $1.34 misses by $0.30, revenue of $6.59B beats by $140M
[8/3/2023 4:03 PM]
78.57 3.04 
(4.02%)
77.19 1.66 
(2.20%)
60.62 - 89.74 7,707,571 6,810,000 18,772
27-04-2023 AH 4:00 PM ET
(Apr 27)
GILD Gilead Sciences, Inc. 106,890 1.37 1.63 2.12 Gilead set to continue revenue beat streak with Q1 results
[4/26/2023 10:55 AM]
82.12 -1.43 
(-1.71%)
83.10 -0.45 
(-0.54%)
57.17 - 89.74 8,115,820 5,580,000 24,321
02-02-2023 AH 4:00 PM ET
(Feb 2)
GILD Gilead Sciences, Inc. 104,540 1.67 1.50 0.69 84.50 3.11 
(3.81%)
84.40 3.01 
(3.70%)
57.17 - 89.74 10,304,914 7,330,000 36,542
27-10-2022 AH 4:00 PM ET
(Oct 27)
GILD Gilead Sciences, Inc. 87,230 1.90 1.44 2.65 Gilead Sciences Non-GAAP EPS of $1.90 beats by $0.47, revenue of $7.04B beats by $910M, raises FY22 outlook
[10/27/2022 4:03 PM]
79.36 9.16 
(13.05%)
74.21 4.01 
(5.71%)
57.16 - 79.61 24,280,724 7,320,000 303,506
02-08-2022 AH 4:00 PM ET
(Aug 2)
GILD Gilead Sciences, Inc. 76,260 1.58 1.51 1.87 Gilead Sciences Non-GAAP EPS of $1.58 beats by $0.06, revenue of $6.26B beats by $390M, raises FY22 EPS guidance
[8/2/2022 4:04 PM]
62.24 2.70 
(4.53%)
60.80 1.26 
(2.12%)
57.16 - 74.12 8,020,575 6,410,000 34,996
28-04-2022 AH 4:00 PM ET
(Apr 28)
GILD Gilead Sciences, Inc. 77,570 2.12 1.77 2.08 Gilead Sciences Non-GAAP EPS of $2.12 beats by $0.31, revenue of $6.59B beats by $310M
[4/28/2022 4:04 PM]
59.32 -2.24 
(-3.64%)
61.61 0.05 
(0.08%)
57.19 - 74.12 7,390,952 7,690,000 3,133
01-02-2022 AH 4:00 PM ET
(Feb 1)
GILD Gilead Sciences, Inc. 84,380 0.69 1.50 2.19 Gilead Sciences Non-GAAP EPS of $1.87 beats by $0.26, revenue of $7.24B beats by $600M
[2/1/2022 4:05 PM]
65.79 -2.68 
(-3.91%)
65.70 -2.77 
(-4.05%)
61.39 - 74.12 16,213,828 10,570,000 367,082
28-10-2021 AH 4:00 PM ET
(Oct 28)
GILD Gilead Sciences, Inc. 84,920 2.65 1.72 2.11 Gilead Sciences EPS beats by $0.87, beats on revenue, boost FY21 outlook
[10/28/2021 4:04 PM]
64.84 -2.50 
(-3.72%)
65.90 -1.44 
(-2.14%)
56.56 - 73.34 11,897,178 5,400,000 85,078
29-07-2021 AH 4:00 PM ET
(Jul 29)
GILD Gilead Sciences, Inc. 86,450 1.87 1.76 1.11 Gilead Sciences EPS beats by $0.12, beats on revenue
[7/29/2021 4:04 PM]
68.27 -1.56 
(-2.23%)
68.69 -1.14 
(-1.63%)
56.56 - 72.60 7,563,844 5,840,000 22,411
29-04-2021 AH 4:00 PM ET
(Apr 29)
GILD Gilead Sciences, Inc. 82,800 2.08 2.06 1.68 Gilead Sciences EPS misses by $0.04, misses on revenue
[4/29/2021 4:04 PM]
63.36 -0.48 
(-0.75%)
62.40 -1.44 
(-2.26%)
56.56 - 85.67 10,215,989 6,870,000 55,426
04-02-2021 AH 4:00 PM ET
(Feb 4)
GILD Gilead Sciences, Inc. 81,640 2.19 2.11 1.10 Gilead Sciences EPS beats by $0.04, beats on revenue
[2/4/2021 4:02 PM]
68.38 2.55 
(3.87%)
67.28 1.45 
(2.20%)
56.56 - 85.97 13,068,102 7,804,377 100,656
28-10-2020 AH 4:00 PM ET
(Oct 28)
GILD Gilead Sciences, Inc. 75,170 2.11 1.83 1.65 Gilead Sciences EPS beats by $0.22, beats on revenue
[10/28/2020 4:03 PM]
58.53 -0.19 
(-0.32%)
57.98 -0.74 
(-1.26%)
57.04 - 85.97 12,013,722 12,641,741 158,380
30-07-2020 AH 4:00 PM ET
(Jul 30)
GILD Gilead Sciences, Inc. 92,480 1.11 1.51 1.72 Gilead Sciences EPS misses by $0.34, misses on revenue
[7/30/2020 4:03 PM]
68.71 -3.62 
(-5.01%)
69.76 -2.57 
(-3.55%)
60.89 - 85.97 9,829,391 6,908,440 163,847